This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2019 Dec:3:1-3.

doi: 10.1200/PO.19.00108.

Leveraging Clinical Tumor-Profiling Programs to Achieve Comprehensive Germline-Inclusive Precision Cancer Medicine

Saud H AlDubayan^{1

2

3}

Affiliations

Affiliations

¹ Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
² The Broad Institute of MIT and Harvard, Cambridge, MA.
³ Brigham and Women's Hospital, Boston, MA.

PMID: 35100696
DOI: 10.1200/PO.19.00108

Editorial

Leveraging Clinical Tumor-Profiling Programs to Achieve Comprehensive Germline-Inclusive Precision Cancer Medicine

Saud H AlDubayan. JCO Precis Oncol. 2019 Dec.

. 2019 Dec:3:1-3.

doi: 10.1200/PO.19.00108.

Author

Saud H AlDubayan^{1

2

3}

Affiliations

¹ Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA.
² The Broad Institute of MIT and Harvard, Cambridge, MA.
³ Brigham and Women's Hospital, Boston, MA.

PMID: 35100696
DOI: 10.1200/PO.19.00108

No abstract available

PubMed Disclaimer

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.